Search results
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Zacks via Yahoo Finance· 13 hours agoData from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study...
Christina Applegate’s early MS symptoms make it clear that the disease can be mistaken for everyday...
Fortune via Yahoo Finance· 11 hours agoMaybe it's that new office chair I've been sitting in that's causing that tingling sensation going...
ADHD looks different in adults: How to recognize the symptoms and get a diagnosis
Fortune via AOL· 4 days ago“We will also ask about if they were having these problems growing up—if they had similar symptoms...
J&J’s seltorexant meets all endpoints in Phase III MDD trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoThe Phase III randomised, double-blind, multicentre, placebo-controlled study achieved all primary...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga via Yahoo Finance· 1 day agoWednesday, Johnson & Johnson (NYSE:JNJ) announced topline results from Phase 3 MDD3001 clinical...
J&J’s daily add-on pill improves depression and insomnia symptoms, acing phase 3
FierceBiotech· 2 days agoJohnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants ...
...Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical...
WJTV Jackson· 3 days ago... of NRX-101 (D-cycloserine/lurasidone) to Lurasidone for Adults with Bipolar Depression and Subacute Suicidal Ideation or Behavior"NRX-101 demonstrated a similar antidepressant...reduction in time to sustained remission from suicidality (P=.05) compared to lurasidoneNRX-101 demonstrated a 76%...
The first pill for postpartum depression is finally getting to patients. Doctors say it’s working.
NBC News via Yahoo News· 6 days agoThe first-ever pill for postpartum depression, zuranolone, was approved last year. Doctors are...
Researchers harness the power of AI to match patients with the most effective antidepressant for...
Medical Xpress· 12 hours agoAI helped to simplify the very complex task of making thousands of guidelines easily accessible to...
...Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 3 days agoStatistical significance was achieved in reporting of at least minimally improved symptoms of depression as assessed by physicians using the Clinical ...